CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...

CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...

"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by ...

Companies developing therapies for rare diseases could find it easier to bring their treatments to market after the FDA ...

Support vector machines improve classification by mapping inseparable signals into higher-dimensional spaces. Random forest models, through ensemble decision trees, increase robustness against ...

Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...

Chemistry World provides expert, independent science journalism for the global chemical science community. We are part of the ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...

The FDA has proposed new guidelines to expedite the approval of customized treatments for rare diseases, creating a streamlined pathway for bespoke therapies that could address unmet medical needs.

The FDA released a much-anticipated draft guidance on how makers of rare disease genetic medicines can leverage a platform ...

Background Gut microbiota dysbiosis is linked to autism spectrum disorder (ASD) in children. However, the role of bacterial ...